Vetoquinol is pleased to announce the creation of the:
VETOQUINOL Cat Mobility Program Clinical Study Grant.
The selection committee for 2022 is chaired by Dr. Margaret E. Gruen, DVM, MVPH, PhD, DACVB, Fear Free Certified. Assistant Professor of Behavioral Medicine of North Carolina State University (NCSU).
The remainder of the Committee will be composed of Vetoquinol personnel across divisions and disciplines based on the relevance of the research proposed. Vetoquinol may use other academic consultants under confidentiality agreements to help with the review process. The selected Research Study proposal will be awarded a grant of up to a maximum amount of fifty thousand euros (€50,000).
The objective of the Grant Program is to fund research for management of cat’s mobility which will result in publication in a peer reviewed veterinary journal.
Research Study proposals will be evaluated based upon the scientific interest of the research and the feasibility of timely completion and publication.
It is expressly understood and agree the Candidates and particulary the winner(s) that any patentable results of the Research Study will be solely owned by VETOQUINOL which shall alone decide to file patent application based on said results. In the event that the filing of a patent application is being contemplated by VETOQUINOL any publication or communication related to the results shall be deferred upon VETOQUINOL’s mere request, which deferral shall last until the application is published.
• Applicants must be a veterinarian either with or in the process of obtaining an advanced degree. Proposals that include interns, residents, or graduate students must have a sponsor in a faculty position or postdoctoral career appointment at the same institute.
• Proposals will be submitted using the ad-hoc template and will be evaluated based upon the scientific interest of the research and the feasibility of timely completion and publication.
• Studies comparing oral supplements with medicinal drugs for non-inferiority or equivalence will not be considered.
• The maximum award for the study will be 50.000€. University overhead fees, fees of publication and fees for the use of validated scores´ copyright (if applicable) should be considered and included in the total quotation.
• Maximum time for completion of the study will be two years with the milestone of a last patient last visit after 12 months of the initiation of the study maximum.
• The primary aim of the award is to publish the results of the research study in a peerreviewed veterinary journal with a deadline of 31st December 2024.
• Vetoquinol will be acknowledged in any publication.
• Investigators will comply with all local ethical requirements.
• Progress will be updated in monthly meetings.
• Reports will be provided every 6 months.
•The Grant will not pay for full-time faculty salaries or will be used for the purchase of any veterinary equipment or medical devices.
• Models for ad-hoc data capture forms (only for awarded winner) should be provided by the investigator.
Should be included with divisions by major categories of expense if possible (e.g. animal care, laboratory assays, purchase of study products...). Itemized budgets will be required if the project is relacted for funding. The maximum budget amount is 50,000 Euros. Residual founds will be required to be retourned at the end of (2) years.
The Vetoquinol Grant will not pay for full-time faculty salaries or will be used for the purchase of any veterinary equipment or medical devices.
The timeline should be included with appropriate major milestones.
Maximum time for completion of the study is two years with a milestone of a last-patient-last visit after 12 months of the initiation of the study maximum.
The candidate(s) selected by the Committee shall provide an intermediate or final report, depending on the progress of the Research Study, before 1 July 2024.
Interim reports shall be provided every six months by the Candidate until submission of the scientific publication based on the final report, which should occur by 31 December 2024.
For further information about submission, please contact your local Vetoquinol Technical Advisor.
Deadline for submission: 2022, October 1st
Results of grant allocation: 2022, December 15th